Ajax Therapeutics
ajaxtherapeutics.com
Health Care
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$140.4M
3 rounds on record
Latest round
$95M
Venture round · Apr 2024 · 2 yr ago
Backers
1
EcoR1 Capital
The money's age
Long since its last round
29 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 26, 2024
Raised a round Venture round $95M · SEC Form D
Jun 1, 2021
Board appointment Scott Platshon, Director · SEC Form D
May 17, 2021
Raised a round Venture round $37.4M · SEC Form D
Jun 12, 2019
Raised a round Venture round $8M · SEC Form D
2019
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Apr 2024 | $95M | — | SEC Form D |
| Venture round | May 2021 | $37.4M | — | SEC Form D |
| Venture round | Jun 2019 | $8M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Ajax Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Martin VogelbaumExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
EcoR1 Capital Overview
Learn about our wholly-owned subsidiaries, which are vital to our pursuit of breakthrough science and speeding the discovery and development of life-changing medicines.
People
Martin Vogelbaum
Executive Officer, Director
Ross Levine
Director
Ramy Farid
Director
David Schnell
Director
Scott Platshon
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York
United States
HQ